SAVA News Explorer
Stay informed with the latest market news and analysis about SAVA
2024-10-02
Officials Cast Doubt on a Dementia Drug, but Human Trials Continue
Oct 2, 2024, 3:41 PM
The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.